摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

putaminoxin | 172104-03-9

中文名称
——
中文别名
——
英文名称
putaminoxin
英文别名
(5S,6E,9R)-5-hydroxy-9-propyl-6-nonen-9-olide;(5S,9R)-(-)-putminoxin;(6R,10R,E)-6-hydroxy-10-propyl-3,4,5,6,9,10-hexahydro-2H-oxecin-2-one;(2R,4E,6S)-6-hydroxy-2-propyl-2,3,6,7,8,9-hexahydrooxecin-10-one
putaminoxin化学式
CAS
172104-03-9
化学式
C12H20O3
mdl
——
分子量
212.289
InChiKey
SQAZDQDTNRHIGZ-NNPIPJJVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    3

SDS

SDS:b43a45f00ddc3b21d3ad029931f3ca26
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    参考文献:
    名称:
    Novel Synthesis of Stagonolide-F, Putaminoxin and Aspinolide-A
    摘要:
    通过利用(S)和(R)-苹果酸,实现了普他米诺辛、芪内酯-F 和芪内酯-A 的新合成。合成策略的主要特点包括霍纳-维蒂希烯化、双键还原和斯特利希酯化。使用布朗不对称烯丙基硼化法制备了普他米诺辛和拮抗内酯-F 的烯烃酸,而使用(R)-苹果酸制备了阿斯匹灵-A 的烯烃酸,并制备了普他米诺辛、拮抗内酯-F 和阿斯匹灵-A 的烯烃醇。
    DOI:
    10.2174/157017811794697502
点击查看最新优质反应信息

文献信息

  • The first chemoenzymatic total synthesis of the phytotoxic nonenolide putaminoxin and its (5S,6E,9S)-diastereomer
    作者:David Dickmann、Martin Diekmann、Claudia Holec、Jörg Pietruszka
    DOI:10.1016/j.tet.2018.12.027
    日期:2019.2
    to a valuable building block for the total synthesis of phytotoxic nonenolide putaminoxin. The enzymatic approach towards the enantioenriched homoallylic alcohol was compared to classical, nonenzymatic approaches using asymmetric reagent controlled allyl additions and the obtained building block was used for the total synthesis of putaminoxin and its (5S,6E,9S)-diastereomer. After the spectroscopic
    研究了醇脱氢酶在含有烷基链的均烯丙基醇的氧化动力学拆分方面的局限性,从而为植物毒性壬烯内酯腐胺毒素的全合成提供了有价值的基础。使用不对称试剂控制的烯丙基加成,将酶促方法与对映体富集的烯丙醇的传统酶方法与传统的非酶方法进行了比较,并将所获得的结构单元用于腐胺蛋白及其(5 S,6 E,9 S)-非对映异构体。对合成的化合物进行光谱分析后,观察到已发表的分离和合成的腐胺毒素数据存在差异。因此,对NMR数据进行了系统的比较。结果强调了对配置的绝对分配进行全面综合的必要性。
  • The first total synthesis of putaminoxin and determination of its absolute configuration
    作者:Gowravaram Sabitha、K. Yadagiri、R. Swapna、J.S. Yadav
    DOI:10.1016/j.tetlet.2009.07.055
    日期:2009.9
    Asymmetric synthesis of putaminoxin, a phytotoxic macrolide from the cultured dinoflagellate Amphidinium sp., has been accomplished. Absolute configuration of putaminoxin was concluded to be 1 from comparison of the NMR data and [α]D values of synthetic and natural putaminoxin.
    已从培养的鞭毛鞭毛双歧杆菌属物种中完成了对植物毒素大环内酯类腐胺毒素的不对称合成。从合成和天然Putaminoxin的NMR数据和[α] D值的比较,可以得出Putaminoxin的绝对构型为1。
  • Stereoselective Total Synthesis of Putaminoxin
    作者:Jhillu Yadav、Ande Raju、Kontham Ravindar、Basi Reddy、Ahmad Khazim Al Ghamdi
    DOI:10.1055/s-0031-1290156
    日期:2012.2
    The stereoselective total synthesis of a phytotoxic macrolide putaminoxin, isolated from the culture of Phoma putaminum fungus, has been accomplished by utilization of Sharpless asymmetric epoxidation, Birch reduction, Jacobsen’s kinetic resolution of racemic epoxide, and Yamaguchi lactonization as key transformations. macrolide - necrotic leaf disease - Sharpless asymmetric epoxidation - Birch reduction
    从腐霉菌的培养物中分离出的一种植物毒性大环内酯类腐胺毒素的立体选择性全合成,已通过利用Sharpless不对称环氧化,桦木还原,雅各布森的消旋环氧化物的动力学拆分以及Yamaguchi内酯化来完成。 大环内酯类-坏死性叶病-锐利的不对称环氧化-桦木还原-Jacobsen的动力学拆分-山口内酯化
  • Novel Synthesis of Stagonolide-F, Putaminoxin and Aspinolide-A
    作者:Ahmed Kamal、Papagari Venkat Reddy、Moku Balakrishna、Singaraboina Prabhakar
    DOI:10.2174/157017811794697502
    日期:2011.2.1
    Novel synthesis of putaminoxin, stagonolide-F and aspinolide-A have been achieved by utilizing (S) and (R)- malic acid. The key feature of the synthetic strategy includes Horner-Wittig olefination, double bond reduction and Steglich esterification. Olefinic acid for putaminoxin and stagonolide-F was prepared from (S)-malic acid whereas olefinic acid for aspinolide-A was prepared from (R)-malic acid and olefinic alcohols for putaminoxin, stagonolide-F and aspinolide-A were prepared by using Browns asymmetric allylboration.
    通过利用(S)和(R)-苹果酸,实现了普他米诺辛、芪内酯-F 和芪内酯-A 的新合成。合成策略的主要特点包括霍纳-维蒂希烯化、双键还原和斯特利希酯化。使用布朗不对称烯丙基硼化法制备了普他米诺辛和拮抗内酯-F 的烯烃酸,而使用(R)-苹果酸制备了阿斯匹灵-A 的烯烃酸,并制备了普他米诺辛、拮抗内酯-F 和阿斯匹灵-A 的烯烃醇。
查看更多

同类化合物

胰岛素原(cattle),29-[N6-[[2-(甲磺酰)乙氧基]羰基]-L-赖氨酸]-59-[N6-[[2-(甲磺酰)乙氧基]羰基]-L-赖氨酸]-(9CI) 十氢-2,7-苯并二氧杂环癸烷-3,6-二酮 二环<3.3.0>-2-氧杂-5-(2-丙烯基)-1-辛烯 乙烯邻苯二甲酸酯 [(E,1R)-1-[(2R,4Z,7S,8R)-7-溴-8-乙基-3,6,7,8-四氢-2H-氧杂环辛三烯-2-基]己-3-烯-5-炔基]乙酸酯 [(2R,3S,4E,6R,7S)-6,7-二羟基-2-甲基-10-氧代-2,3,6,7,8,9-六氢氧杂环辛三烯-3-基] (E)-丁-2-烯酸酯 6,7-二氢-5aH-氧杂环丁烷并[3,2-d][1,3]苯并二氧戊环 5-氧杂-10-氮杂三环[5.3.1.03,8]十一碳-1(10),2,6,8-四烯 3-氧杂二环[3.3.1]壬-6-烯-9-酮 3,4,5,6-四氢-2,7-苯并二氧杂环癸烷e-1,8-二酮 10-(乙酰氧基)-4,5,6,7-四氢-2H-1-苯并氧杂环辛三烯-2,8(3H)-二酮 1-(2,3,4,5-四氢-1,6-苯并二噁辛英-8-基)丙烷-1-酮 1,2-环己烷二甲酸1-甲基-1,2-乙二基酯 (S)-5-烯丙基-2-氧杂双环[3.3.0]辛-8-烯 (7Z)-2-(3-溴丙-1,2-二烯基)-5-(1-溴丙基)-3,3a,5,6,9,9a-六氢-2H-呋喃并[3,2-b]氧杂环辛三烯 (7E)-4,7-二羟基-10-甲基-3,4,5,6,9,10-六氢氧杂环辛三烯-2-酮 (6Z)-10-甲基-3,4,5,8,9,10-六氢-2H-氧杂环辛三烯-2-酮 (5Z,8S)-3-氯-2-[(E)-戊-2-烯-4-炔基]-8-[(E)-丙-1-烯基]-3,4,7,8-四氢-2H-氧杂环辛三烯 (4Z)-3,6-二氢-2,7-苯并二氧杂环癸烷e-1,8-二酮 (4S,5Z,7S,8S,10R)-4,7,8-三羟基-10-甲基-3,4,7,8,9,10-六氢氧杂环辛三烯-2-酮 (4R,5R,6Z,8S,10R)-4,5,8-三羟基-10-甲基-3,4,5,8,9,10-六氢氧杂环辛三烯-2-酮 (2R,5Z)-8a-[(R)-1-溴丙基]-3a-氯-3,4,7,8-四氢-2a-[(Z)-2-戊烯-4-炔基]-2H-氧杂环辛三烯 1,3,3a,6a-tetrahydro-5-pentyl-4H-cyclopentafuran-4-one trans-1-oxacyclodec-7-ene-2-one 2-epi-herbarumin II (RS)-5-methoxy-2,3,5,6-tetrahydro-8H-benzo[1,4,7]trioxecin β-heptenolactone stagonolide-E fumaric acid butanediyl ester aspinolide A (3R,4R,9S,10R,Z)-4,9-dihydroxy-3-methyl-10-pentyl-3,4,7,8,9,10-hexahydro-2H-oxecin-2-one prelaureatin 8-acetyl-4,4-dimethyl-2,6-dioxo-9-(2-methylpropyl)-2,3,4,5,6,8-hexahydrooxocino[2,3-c]pyrrole 5,6-benzo-2,3-diethoxy-4-oxo-2-hepten-7-olide 3,4,5,6-tetrahydro-oxocin-2-one (Z)-3-butyl-5,6,7,8-tetrahydro-2H-oxocin-2-one presaccharothriolide X 1-{2-[4,5-dihydro-1H-2-benzoxocin-(6Z)-ylidenemethyl]-allyl}-piperidine (R,Z)-8-(methoxymethoxy)-2,2,6,9-tetramethyl-5,6-dihydro-2H-benzo[b]oxocine 5-hydroxy-7R,11-heliannan-10-one 8-methoxy-2,2,6,9-tetramethyl-2H-1-benzoxocin-3(4H)-one 8-methoxy-2,2,6,9-tetramethyl-3,4,5,6-tetrahydro-2H-1-benzoxocin-3-ol (4S,5Z,10R)-4-hydroxy-10-methyl-3,4,7,8,9,10-hexahydro-2H-oxecin-2-one (4R)-9,11-bis(benzyloxy)-4-methyl-4,5,6,7-tetrahydro-1H-benzo[d]-oxecine-2,8-dione ethyl (4Z)-4-methyl-7,8-dihydro-1,3,6-trioxocine-5-carboxylate 4-hydroxy-10-(2-hydroxyethyl)-1,2-dihydro-4,12a-methanooxocino[4,5-b][1,4]benzodioxin-5-one 4-hydroxy-9-(2-hydroxyethyl)-1,2-dihydro-4,12a-methanooxocino[4,5-b][1,4]benzodioxin-5-one (7R,9R,5E)-7-hydroxy-9-propylnon-5-en-9-olide (6S,7R,9R)-6,7-dihydroxy-9-propylnon-4-eno-9-lactone 7-[2-(3,5-Dichloro-N-oxo-pyridin-4-yl)-1-oxoethyl]-10-methoxy-2,3,4,5-tetrahydro-1,6-benzodioxocine